Atom Investors LP Atara Biotherapeutics, Inc. Transaction History

Atom Investors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.44 - $1.22 $13,819 - $38,317	31,408 New	31,408 $21,000
Q2 2021 Aug 16, 2021	SELL	$12.89 - $16.58 $453,263 - $583,019	-35,164 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$14.0 - $20.72 $1.12 Million - $1.66 Million	-80,341 Reduced 69.56%	35,164 $505,000
Q4 2020 Feb 16, 2021	BUY	$12.67 - $26.23 $1.17 Million - $2.41 Million	91,996 Added 391.32%	115,505 $2.27 Million
Q3 2020 Nov 13, 2020	BUY	$11.92 - $15.87 $280,227 - $373,087	23,509 New	23,509 $305,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.26B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.